Skip to main content
SpringerLink
Log in

Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Systemic and local administration of the bacterium Corynebacterium parvum (more accurately known as Propionibacterium acnes) is reported to exert antitumor action via activated macrophages or short-lived cytotoxic T lymphocytes (CTL), respectively. This study examined the effect of C. parvum treatment on resulting in vitro interleukin levels, which are components in the sequence of events leading to the development of effective CTL. C. parvum administration prevented palpable fibrosarcoma development. This was concomitant with restoration and maintenance of normal interleukin-2 (IL-2) and interleukin-3 (IL-3) levels and prevention of suppressor cell development in mice injected with both tumor cells and vaccine. Our finding of C. parvum-induced maintenance of IL-2 and IL-3 levels and apparent lack of suppressor cell formation lends support to the idea of local C. parvum antitumor action possibly being mediated by CTL arising via the interleukin cascade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bomford R (1975) Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells. Br J Cancer 32:551

    Google Scholar 

  2. Burger CJ, Elgert KD (1982) Interleukin 2 activity in fibrosarcoma-bearing hosts. Fed Proc 41:318

    Google Scholar 

  3. Burger CJ, Elgert KD, Farrar WL (1984) Interleukin 2 activity during tumor growth: IL 2 production kinetics, absorption of and responses to exogenous IL 2. Cell Immunol 84:228

    Google Scholar 

  4. Burger CJ, Elgert KD, Tyson JJ, Birch JB (1985) An improved data analysis for interleukin 2 microassay. Comput Biol Med (In press)

  5. Castro JE (1974) Antitumor effects of Corynebacterium parvum in mice. Eur J Cancer 10:121

    Google Scholar 

  6. Chouaib S, Chatenoud L, Klatzmann D, Fradelizi D (1984) The mechanisms of inhibition of human IL-2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol 132:1851

    Google Scholar 

  7. Conlon PJ, Ramthun CA, Henney CS, Gillis S (1982) Cytokine-dependent thymocyte responses. II. Generation of cytotoxic T lymphocytes from immature thymocytes. J Immunol 129:11

    Google Scholar 

  8. Conlon PJ, Hefeneider SH, Henney CS, Gillis S (1982) The effects of interleukin 2 on primary in vivo immune responses. In: The potential role of T cells in cancer therapy. Raven Press, New York, p 113

    Google Scholar 

  9. Cummins CS, Linn DM (1977) Reticulostimulating properties of killed vaccines of anaerobic coryneforms and other organisms. J Natl Cancer Inst 59:1697

    Google Scholar 

  10. Denbow CJ, Conroy JM, Elgert KD (1984) Macrophage-derived prostaglandin E modulation of the mixed lymphocyte reaction: An anomaly of increased production and decreased T cell susceptibility during tumor growth. Cell Immunol 84:1

    Google Scholar 

  11. Elgert KD (1980) In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. I. Correlation with in vitro studies. Cell Immunol 49:395

    Google Scholar 

  12. Elgert KD, Connolly KM (1978) Macrophage regulation of the T cell allogeneic response during tumor growth. Cell Immunol 35:1

    Google Scholar 

  13. Elgert KD, Farrar WL (1978) Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. J Immunol 120:1345

    Google Scholar 

  14. Evans SR, Johnson HM (1981) The induction of least two distinct types of interferon in mouse spleen cell cultures by Corynebacterium parvum. Cell Immunol 64:64

    Google Scholar 

  15. Farrar WL, Johnson HM, Farrar JJ (1981) Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol 126:1120

    Google Scholar 

  16. Fontana A, Hengartner H, deTribolet N, Weber E, Palacious R (1984) Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132:1837

    Google Scholar 

  17. Garland JM (1984) Involvement of interleukin 3 in lymphocyte biology and leukemogenesis. Lymphokines 9:154

    Google Scholar 

  18. Garner RE, Malick AP, Connolly KM, Elgert KD (1984) In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. II. Regulation by cytokines and T cells via adoptive transfer. Cancer Immunol Immunother 18:135

    Google Scholar 

  19. Gillis S, Ferm MM, Ou W, Smith KA (1978) T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120:2027

    Google Scholar 

  20. Halpern BN, Biozzi G, Stiffel C, Mouton D (1966) Inhibition of tumor growth by administration of killed Corynebacterium parvum. Nature 212:853

    Google Scholar 

  21. Hersey P, Bindon C, Czerniecki M, Spurling A, Wass J, McCarthy WH (1983) Inhibition of interleukin 2 production by factors released from tumor cells. J Immunol 131:2837

    Google Scholar 

  22. Hirt HM, Becker H, Kirchner H (1978) Induction of interferon production in mouse spleen cell cultures by Corynebacterium parvum. Cell Immunol 38:168

    Google Scholar 

  23. Ihle JN, Peppersack L, Rebar L (1981) Regulation of T cell differentiation: In vitro induction of 20-alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. J Immunol 126:2184

    Google Scholar 

  24. Ihle JN, Keller J, Henderson L, Klein F, Palasznski E (1982) Procedures for the purification of interleukin 3 to homogeneity. J Immunol 129:2431

    Google Scholar 

  25. Ihle JN, Rebar L, Keller J, Lee JC, Hapel AJ (1982) Interleukin 3: Possible roles in the regulation of lymphocyte differentiation and growth. Immunol Rev 63:5

    Google Scholar 

  26. Ihle JN, Keller J, Greenberger JS, Henderson L, Yetter RA, Morse HC (1982) Phenotypic characteristics of cell lines requiring interleukin 3 for growth. J Immunol 129:1377

    Google Scholar 

  27. Julius MH, Simpson E, Herzenberg LA (1973) A rapid method for the isolation of functional thymus derived murine lymphocytes. Eur J Immunol 3:645

    Google Scholar 

  28. Jurin M, Suit HD (1978) In vitro activity of lymphocytes and serum of C3HF/Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation. Cancer Res 34:672

    Google Scholar 

  29. Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ (1983) Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol 130:1784

    Google Scholar 

  30. Knop J, Reichman R, Macher E (1981) Modulation of suppressor mechanism in allergic contact dermatitis. IV. Selective inhibition of suppressor T-lymphocytes by serum obtained from Corynebacterium parvum treated mice. J Invest Dermatol 77:469

    Google Scholar 

  31. Knop J, Reichmann R, Macher E (1981) Modulation of suppressor mechanisms in allergic contact dermatitis: 1. Effect of C. parvum on the induction phase of contact allergy. J Invest Dermatol 76:193

    Google Scholar 

  32. Mills GB, Paetkau V (1980) Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (interleukin 2). J Immunol 125:1897

    Google Scholar 

  33. Okamura H, Kawaguchi K, Shoji K, Kawade Y (1982) High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect Immun 38:440

    Google Scholar 

  34. Paetkau V, Mills GB, Bleackley RC (1982) Enhancement of anti-tumor immune responses with interleukin 2. In: The potential role of T cells in cancer therapy. Raven Press, New York, p 147

    Google Scholar 

  35. Paranjpe MS, Boone CW (1974) Kinetics of the anti-tumor delayed hypersensitivity response in mice with progressively growing tumors: Stimulation followed by specific suppression. Int J Cancer 13:187

    Google Scholar 

  36. Rappaport RS, Dodge GR (1982) Prostaglandin E inhibits the production of human interleukin-2. J Exp Med 155:943

    Google Scholar 

  37. Scott MT (1974) Corynebacterium parvum a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection. J Natl Cancer Inst 53:855

    Google Scholar 

  38. Tuttle RL, North RJ (1976) Mechanisms of antitumor action of Corynebacterium parvum: Replicating short-lived T-cells as the mediators of potentiated tumor specific immunity. J Reticuloendothel Soc 20:209

    Google Scholar 

  39. Wagner H, Hardt C, Heeg K, Pfizenmaier K, Solbach W, Bartlett R, Stockinger H, Rollinghoff M (1980) T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor interleukin 2 as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors. Immunol Rev 51:215

    Google Scholar 

  40. Walker C, Kristensen F, Bettens F, deWeck AL (1983) Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol 130:1770

    Google Scholar 

  41. Wolf M, Droege W (1982) Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2. Cell Immunol 72:286

    Google Scholar 

  42. Woodruff MFA, Boak JL (1966) Inhibitory effect of injection of Corynebacterium parvum on the growth of tumor transplants in isogeneric hosts. Eur J Cancer 20:345

    Google Scholar 

  43. Woodruff MFA, Warner NL (1977) Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice. J Natl Cancer Inst 58:111

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Microbiology Section, Department of Biology, Virginia Polytechnic Institute and State University, 24061, Blacksburg, VA, USA

    Alice M. Roberson & Klaus D. Elgert

Authors
  1. Alice M. Roberson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klaus D. Elgert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roberson, A.M., Elgert, K.D. Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity. Cancer Immunol Immunother 22, 49–55 (1986). https://doi.org/10.1007/BF00205716

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205716

Keywords

Search

Navigation